Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration

Journal of Orthopaedic Research

Volumn 22, Issue 1, 2004, Pages 73-79

  Pelissier, Philippe ^a   Masquelet, A C ^b   Bareille, R ^c   Mathoulin Pelissier, S ^d   Amedee, J ^c  

^a HÔPITAL PELLEGRIN   (France)

^b AVICENNE HOSPITAL   (France)

^c INSERM   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; BONE MORPHOGENETIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE REGENERATION; CANCELLOUS BONE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RABBIT; STROMA CELL; SYNOVIUM; VASCULARIZATION;

EID: 0346964738     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00165-7     Document Type: Article

References (25)

1. Cattaneo R, Catagni M, Johnson E. The treatment of infected nonunions and segmental defects of the tibia by the methods of Ilizarov. Clin Orthop 1992;280:143-52.
2. de Boer H, Wood M. Bone changes in the vascularised fibular graft. J Bone Joint Surg 1989;71B:374-8.
3. Deckers M, Karperien M, van der Bent C, et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000;141:1667-74.
4. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143:1545-53.
5. Ducy P, Karsenty G. The family of bone morphogenetic protein. Kidney Int 2000;57:2207-14.
6. Feng J, Hussain M, Constant J, Hunt T. Angiogenesis in wound healing. J Surg Pathol 1998;3:1-8.
7. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
8. Green S, Jackson J, Wall D, Marinow H, Ishkanian J. Management of segmental defects by the Ilizarov intercalary bone transport method. Clin Orthop 1992;280:136-42.
9. Han C, Wood M, Bishop A, Cooney W. Vascularized bone transfer. J Bone Joint Surg 1992;74A:1441-9.
10. Klaue K, Knothe U, Masquelet A. Effet biologique des membranes à corps étranger induites in situ sur la consolidation des greffes d'os spongieux. Rev Chir Orthop Suppl 1995;70e réunion annuelle. p. 109-10.
11. Marie P. Growth factors and bone formation in osteoporosis: role for IGF1 and TGF beta. Rev Rhum Engl 1997;64:44-53.
12. Masquelet A, Fitoussi F, Begue T, Muller G. Reconstruction des os longs par membrane induite et autogreffe spongieuse. Ann Chir Plast Esthet 2000;45:346-53.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
14. Okubo Y, Bessho K, Fujimura K, et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int J Oral Maxillofac Surg 2000;29:62-6.
15. Pelissier P, Casoli V, Demiri E, Martin D, Baudet J. Soleus-fibula free transfer in lower limb reconstruction. Plast Reconstr Surg 2000;105:567-73.
16. Pelissier P, Villars F, Mathoulin-Pelissier S, Bareille R, Lafage-Proust MH, Vilamitjana-Amedee J. Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. Plast Reconstr Surg 2003;111(6):1932-41.
17. Pélissier Ph, Masquelet AC, Lepreux S, Martin D, Baudet J. Behavior of cancellous bone graft placed in induced membranes. Br J Plast Surg 2002;55:598-600.
18. Pfeilschifter J, Diel I, Scheppach B, et al. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J Bone Miner Res 1998;13:716-30.
19. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin; Orthop 1996;324:39-46.
20. Si X, Jin Y, Yang L. Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. Int J Oral Maxillofac Surg 1998;27:310-4.
21. Spinella-Jaegle S, Roman S, Faucheu C, Dunn FW, Kawai S, et al. Opposite effects of bone morphogenetic protein2 and transforming growth factor beta 1 on osteoblast differentiation. Bone 1998;29(4):323-30.
22. Vilamitjana-Amédée J, Bareille R, Rouais F, Caplan AI, Harmand MF. Human bone marrow stromal cells expressing osteoblastic phenotype in vitro. In Vitro Cell Dev Biol 1993;29(9): 699-707.
23. Villars F, Guillotin B, Amdée Th, Dutoya S, Bordenave L, Bareille R, et al. Effect of human endothelial cells on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol 2002;282(4):C775-85.
24. Weiland A. Current concepts review: vascularized free bone transplants. J Bone Joint Surg 1981;63A:166-9.
25. Wyatt L, Sinow J, Wollman J, Sami D, Miller T. The influence of time on human breast capsule histology: smooth and textured silicone-surfaced implants. Plast Reconstr Surg 1998;102:1922-31.